The French pharmaceutical group’s board is scheduled to meet to discuss the planned transaction and finalize measures with CD&R to protect jobs and local plants, the people said, asking not to ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

In September, Bloomberg reported that Sanofi had received two separate bids from CD&R and rival PAI Partners for the Opella unit. CD&R has kept away interest from rival PAI Partners for the unit ...

Clayton Dubilier & Rice is close to completing a deal to buy control of Sanofi’s (NASDAQ:SNY) consumer health unit after signing social commitments with the French government, Bloomberg News ...

CD&R is also considering the French government’s request to keep the consumer health unit’s headquarters in France, said the people, who asked not to be identified as the information is private.

The French finance ministry said in a statement that CD&R was a "serious investment fund" with positive prospects for Opella's development and its plants in France. It added that it would require ...

Citi was advising CD&R on the sale, while Goldman Sachs and Morgan Stanley were sellside advisors. JPMorgan Chase & Co. advised France’s PAI Partners on a rival bid. It’s unclear whether the ...